Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06853158 · ClinicalTrials.gov registry record · NA

MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease

A NA study of Sickle Cell Disease, sponsored by University of California, Irvine.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
2
Study locations

NCT06853158 is a NA study of Sickle Cell Disease that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 90 participants, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (69% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06853158, a NA study of Sickle Cell Disease, is actively recruiting participants, sponsored by University of California, Irvine.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
2
Study locations

Study Summary

This is a multi-site, multi-visit feasibility RCT of music therapy (MT) among adolescent and adult patients (aged 14 and older) with sickle cell disease (SCD). Subjects will be randomized into one of three groups, either (1) 6 visits of in- person MT (InMT:); (2) 1 visit of in-person MT and 5 visits of virtual MT (HybMT); or (3) 1 visit of in-person health education and 5 visits of virtual health education (HybHE). Cohorts of 15 participants (10 at site 1 and 5 site 2) will be recruited each quarter for 6 quarters to reach 90 participants. Cohorts will maintain a semi-structured recruitment, consenting, assessment, and intervention schedule. The primary objective of the study is to examine the feasibility of study. This is defined by 6 metrics: (1) completeness of data collection, (2) participant screening, (3) participant recruitment, (4) participant retention, (5) Individual attendance and (6) Home practice. A final determination of "feasibility" for the study will be met if any 4 of the 6 metrics described above are met. This study will also include a secondary objective of conducting qualitative interviews to assess feasibility of implementation.

Conditions Studied

Sickle Cell Disease

Interventions

  • BEHAVIORAL Music therapy
  • OTHER Health education

Study Locations (2)

Ohio

  • UH Seidman Cancer Center Adult SCD Clinic or UH Rainbow Babies and Children's Hospital Sickle Cell Anemia Center - Cleveland

South Carolina

  • Prisma Health Lifespan Comprehensive SCD Program - Greenville

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2025-04-02
Est. Completion 2027-01-31
Phase NA

Sponsor

University of California, Irvine

368 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06853158

The ClinicalTrials.gov registry entry for NCT06853158 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (69% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sickle Cell Disease appearing as the primary indexed condition, and to 2 interventions - of which Music therapy is the first listed.

NCT06853158 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Ohio, South Carolina.

Frequently Asked Questions

What is clinical trial NCT06853158 about?

NCT06853158 is a clinical study titled "MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease". This is a multi-site, multi-visit feasibility RCT of music therapy (MT) among adolescent and adult patients (aged 14 and older) with sickle cell disease (SCD). Subjects will be randomized into one of three groups, either (1) 6 visits of in- person MT (InMT:); (2) 1 visit of in-person MT and 5 visit...

What is the current status of trial NCT06853158?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2025-04-02. Estimated completion is 2027-01-31.

What conditions does trial NCT06853158 study?

This clinical trial studies the following conditions: Sickle Cell Disease.

What interventions are being tested in trial NCT06853158?

The interventions under investigation include: Music therapy (BEHAVIORAL), Health education (OTHER).

Who is sponsoring clinical trial NCT06853158?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06853158 being conducted?

This trial has 2 study locations across Ohio, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sickle Cell Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Sickle Cell Disease

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.